KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

Current methods for biomarker discovery and target identification in immuno-oncology rely on static snapshots of tumor immunity. To thoroughly characterize the temporal nature of antitumor immune responses, we developed a 34-parameter spectral flow cytometry panel and performed high-throughput analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ager, Casey R, Zhang, Mingxuan, Chaimowitz, Matthew, Bansal, Shruti, Tagore, Somnath, Obradovic, Aleksandar, Jugler, Collin, Rogava, Meri, Melms, Johannes C, McCann, Patrick, Spina, Catherine, Drake, Charles G, Dallos, Matthew C, Izar, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476134/
https://www.ncbi.nlm.nih.gov/pubmed/37657842
http://dx.doi.org/10.1136/jitc-2023-006782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476134/
https://www.ncbi.nlm.nih.gov/pubmed/37657842
http://dx.doi.org/10.1136/jitc-2023-006782

Ejemplares similares